nodes	percent_of_prediction	percent_of_DWPC	metapath
Desipramine—SLC22A2—Cytarabine—lymphatic system cancer	0.167	0.213	CbGbCtD
Desipramine—SLC22A1—Cytarabine—lymphatic system cancer	0.145	0.185	CbGbCtD
Desipramine—SLC22A3—Vincristine—lymphatic system cancer	0.133	0.171	CbGbCtD
Desipramine—CYP1A2—Carmustine—lymphatic system cancer	0.0743	0.0951	CbGbCtD
Desipramine—CYP2E1—Mitoxantrone—lymphatic system cancer	0.0604	0.0773	CbGbCtD
Desipramine—CYP2C19—Teniposide—lymphatic system cancer	0.0541	0.0693	CbGbCtD
Desipramine—ABCB1—Mitoxantrone—lymphatic system cancer	0.0305	0.0391	CbGbCtD
Desipramine—CYP3A4—Cytarabine—lymphatic system cancer	0.0266	0.034	CbGbCtD
Desipramine—CYP3A4—Teniposide—lymphatic system cancer	0.0262	0.0335	CbGbCtD
Desipramine—ABCB1—Vincristine—lymphatic system cancer	0.021	0.0269	CbGbCtD
Desipramine—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0183	0.0234	CbGbCtD
Desipramine—ABCB1—Methotrexate—lymphatic system cancer	0.0127	0.0163	CbGbCtD
Desipramine—CYP3A4—Vincristine—lymphatic system cancer	0.0126	0.0161	CbGbCtD
Desipramine—Stomatitis—Teniposide—lymphatic system cancer	0.00152	0.00696	CcSEcCtD
Desipramine—Disorientation—Bleomycin—lymphatic system cancer	0.00146	0.00668	CcSEcCtD
Desipramine—Sudden death—Methotrexate—lymphatic system cancer	0.00142	0.0065	CcSEcCtD
Desipramine—Gynaecomastia—Carmustine—lymphatic system cancer	0.0014	0.00643	CcSEcCtD
Desipramine—Acute coronary syndrome—Fludarabine—lymphatic system cancer	0.00135	0.00619	CcSEcCtD
Desipramine—Neuropathy peripheral—Fludarabine—lymphatic system cancer	0.00134	0.00615	CcSEcCtD
Desipramine—Myocardial infarction—Fludarabine—lymphatic system cancer	0.00134	0.00615	CcSEcCtD
Desipramine—Stomatitis—Fludarabine—lymphatic system cancer	0.00134	0.00612	CcSEcCtD
Desipramine—Cerebrovascular accident—Bleomycin—lymphatic system cancer	0.00133	0.00609	CcSEcCtD
Desipramine—Thrombocytopenia—Mechlorethamine—lymphatic system cancer	0.00132	0.00605	CcSEcCtD
Desipramine—Flushing—Teniposide—lymphatic system cancer	0.0013	0.00595	CcSEcCtD
Desipramine—Anorexia—Mechlorethamine—lymphatic system cancer	0.00129	0.00589	CcSEcCtD
Desipramine—Arrhythmia—Teniposide—lymphatic system cancer	0.00125	0.00573	CcSEcCtD
Desipramine—Alopecia—Teniposide—lymphatic system cancer	0.00124	0.00567	CcSEcCtD
Desipramine—Hypoaesthesia—Fludarabine—lymphatic system cancer	0.00122	0.00561	CcSEcCtD
Desipramine—Decreased appetite—Mechlorethamine—lymphatic system cancer	0.00117	0.00537	CcSEcCtD
Desipramine—Agitation—Teniposide—lymphatic system cancer	0.00112	0.00513	CcSEcCtD
Desipramine—Arrhythmia—Fludarabine—lymphatic system cancer	0.0011	0.00503	CcSEcCtD
Desipramine—Alopecia—Fludarabine—lymphatic system cancer	0.00109	0.00498	CcSEcCtD
Desipramine—Ataxia—Carmustine—lymphatic system cancer	0.00107	0.0049	CcSEcCtD
Desipramine—Hypertension—Teniposide—lymphatic system cancer	0.00105	0.00482	CcSEcCtD
Desipramine—Liver function test abnormal—Carmustine—lymphatic system cancer	0.00105	0.00481	CcSEcCtD
Desipramine—Urinary retention—Vincristine—lymphatic system cancer	0.00103	0.00473	CcSEcCtD
Desipramine—Ataxia—Vincristine—lymphatic system cancer	0.00102	0.00468	CcSEcCtD
Desipramine—Confusional state—Teniposide—lymphatic system cancer	0.001	0.00459	CcSEcCtD
Desipramine—Oedema—Teniposide—lymphatic system cancer	0.000995	0.00456	CcSEcCtD
Desipramine—Ill-defined disorder—Fludarabine—lymphatic system cancer	0.000994	0.00455	CcSEcCtD
Desipramine—Acute coronary syndrome—Bleomycin—lymphatic system cancer	0.000991	0.00454	CcSEcCtD
Desipramine—Myocardial infarction—Bleomycin—lymphatic system cancer	0.000986	0.00451	CcSEcCtD
Desipramine—Agitation—Fludarabine—lymphatic system cancer	0.000985	0.00451	CcSEcCtD
Desipramine—Stomatitis—Bleomycin—lymphatic system cancer	0.00098	0.00449	CcSEcCtD
Desipramine—Thrombocytopenia—Teniposide—lymphatic system cancer	0.000974	0.00446	CcSEcCtD
Desipramine—Tachycardia—Teniposide—lymphatic system cancer	0.000971	0.00445	CcSEcCtD
Desipramine—Malaise—Fludarabine—lymphatic system cancer	0.000966	0.00442	CcSEcCtD
Desipramine—Pruritus—Mechlorethamine—lymphatic system cancer	0.000955	0.00437	CcSEcCtD
Desipramine—Anorexia—Teniposide—lymphatic system cancer	0.000949	0.00434	CcSEcCtD
Desipramine—Hypotension—Teniposide—lymphatic system cancer	0.00093	0.00426	CcSEcCtD
Desipramine—Convulsion—Fludarabine—lymphatic system cancer	0.000928	0.00425	CcSEcCtD
Desipramine—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.000924	0.00423	CcSEcCtD
Desipramine—Discomfort—Fludarabine—lymphatic system cancer	0.000901	0.00413	CcSEcCtD
Desipramine—Hypoaesthesia—Bleomycin—lymphatic system cancer	0.000898	0.00411	CcSEcCtD
Desipramine—Petechiae—Methotrexate—lymphatic system cancer	0.000883	0.00404	CcSEcCtD
Desipramine—Confusional state—Fludarabine—lymphatic system cancer	0.000882	0.00404	CcSEcCtD
Desipramine—Depression—Carmustine—lymphatic system cancer	0.000875	0.00401	CcSEcCtD
Desipramine—Oedema—Fludarabine—lymphatic system cancer	0.000875	0.004	CcSEcCtD
Desipramine—Erectile dysfunction—Vincristine—lymphatic system cancer	0.000865	0.00396	CcSEcCtD
Desipramine—Decreased appetite—Teniposide—lymphatic system cancer	0.000865	0.00396	CcSEcCtD
Desipramine—Neuropathy peripheral—Carmustine—lymphatic system cancer	0.00086	0.00394	CcSEcCtD
Desipramine—Vomiting—Mechlorethamine—lymphatic system cancer	0.000858	0.00393	CcSEcCtD
Desipramine—Thrombocytopenia—Fludarabine—lymphatic system cancer	0.000856	0.00392	CcSEcCtD
Desipramine—Stomatitis—Carmustine—lymphatic system cancer	0.000855	0.00392	CcSEcCtD
Desipramine—Rash—Mechlorethamine—lymphatic system cancer	0.000851	0.0039	CcSEcCtD
Desipramine—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00085	0.00389	CcSEcCtD
Desipramine—Erectile dysfunction—Mitoxantrone—lymphatic system cancer	0.000843	0.00386	CcSEcCtD
Desipramine—Flushing—Bleomycin—lymphatic system cancer	0.000838	0.00383	CcSEcCtD
Desipramine—Depression—Vincristine—lymphatic system cancer	0.000835	0.00382	CcSEcCtD
Desipramine—Anorexia—Fludarabine—lymphatic system cancer	0.000834	0.00382	CcSEcCtD
Desipramine—Weight increased—Mitoxantrone—lymphatic system cancer	0.000833	0.00381	CcSEcCtD
Desipramine—Acute coronary syndrome—Vincristine—lymphatic system cancer	0.000826	0.00378	CcSEcCtD
Desipramine—Myocardial infarction—Vincristine—lymphatic system cancer	0.000821	0.00376	CcSEcCtD
Desipramine—Neuropathy peripheral—Vincristine—lymphatic system cancer	0.000821	0.00376	CcSEcCtD
Desipramine—Feeling abnormal—Teniposide—lymphatic system cancer	0.00082	0.00375	CcSEcCtD
Desipramine—Stomatitis—Vincristine—lymphatic system cancer	0.000817	0.00374	CcSEcCtD
Desipramine—Drowsiness—Mitoxantrone—lymphatic system cancer	0.000816	0.00374	CcSEcCtD
Desipramine—Acute coronary syndrome—Mitoxantrone—lymphatic system cancer	0.000804	0.00368	CcSEcCtD
Desipramine—Nausea—Mechlorethamine—lymphatic system cancer	0.000802	0.00367	CcSEcCtD
Desipramine—Myocardial infarction—Mitoxantrone—lymphatic system cancer	0.0008	0.00366	CcSEcCtD
Desipramine—Alopecia—Bleomycin—lymphatic system cancer	0.000798	0.00365	CcSEcCtD
Desipramine—Stomatitis—Mitoxantrone—lymphatic system cancer	0.000795	0.00364	CcSEcCtD
Desipramine—Jaundice—Mitoxantrone—lymphatic system cancer	0.000795	0.00364	CcSEcCtD
Desipramine—Urticaria—Teniposide—lymphatic system cancer	0.000791	0.00362	CcSEcCtD
Desipramine—Abdominal pain—Teniposide—lymphatic system cancer	0.000787	0.0036	CcSEcCtD
Desipramine—Body temperature increased—Teniposide—lymphatic system cancer	0.000787	0.0036	CcSEcCtD
Desipramine—Paraesthesia—Fludarabine—lymphatic system cancer	0.000785	0.0036	CcSEcCtD
Desipramine—Hypoaesthesia—Carmustine—lymphatic system cancer	0.000784	0.00359	CcSEcCtD
Desipramine—Hallucination—Carmustine—lymphatic system cancer	0.000784	0.00359	CcSEcCtD
Desipramine—Dyspepsia—Fludarabine—lymphatic system cancer	0.00077	0.00352	CcSEcCtD
Desipramine—Agranulocytosis—Mitoxantrone—lymphatic system cancer	0.000761	0.00349	CcSEcCtD
Desipramine—Decreased appetite—Fludarabine—lymphatic system cancer	0.00076	0.00348	CcSEcCtD
Desipramine—Fatigue—Fludarabine—lymphatic system cancer	0.000754	0.00345	CcSEcCtD
Desipramine—Hypoaesthesia—Vincristine—lymphatic system cancer	0.000748	0.00343	CcSEcCtD
Desipramine—Hallucination—Vincristine—lymphatic system cancer	0.000748	0.00343	CcSEcCtD
Desipramine—Constipation—Fludarabine—lymphatic system cancer	0.000748	0.00342	CcSEcCtD
Desipramine—Hepatitis—Mitoxantrone—lymphatic system cancer	0.000732	0.00335	CcSEcCtD
Desipramine—Flushing—Carmustine—lymphatic system cancer	0.000731	0.00335	CcSEcCtD
Desipramine—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.000729	0.00334	CcSEcCtD
Desipramine—Feeling abnormal—Fludarabine—lymphatic system cancer	0.000721	0.0033	CcSEcCtD
Desipramine—Asthenia—Teniposide—lymphatic system cancer	0.000714	0.00327	CcSEcCtD
Desipramine—Malaise—Bleomycin—lymphatic system cancer	0.000709	0.00324	CcSEcCtD
Desipramine—Pruritus—Teniposide—lymphatic system cancer	0.000704	0.00322	CcSEcCtD
Desipramine—Arrhythmia—Carmustine—lymphatic system cancer	0.000704	0.00322	CcSEcCtD
Desipramine—Alopecia—Carmustine—lymphatic system cancer	0.000696	0.00319	CcSEcCtD
Desipramine—Body temperature increased—Fludarabine—lymphatic system cancer	0.000691	0.00317	CcSEcCtD
Desipramine—Diarrhoea—Teniposide—lymphatic system cancer	0.000681	0.00312	CcSEcCtD
Desipramine—Alopecia—Vincristine—lymphatic system cancer	0.000665	0.00304	CcSEcCtD
Desipramine—Discomfort—Bleomycin—lymphatic system cancer	0.000661	0.00303	CcSEcCtD
Desipramine—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.000654	0.003	CcSEcCtD
Desipramine—Gynaecomastia—Methotrexate—lymphatic system cancer	0.00065	0.00298	CcSEcCtD
Desipramine—Alopecia—Mitoxantrone—lymphatic system cancer	0.000647	0.00296	CcSEcCtD
Desipramine—Confusional state—Bleomycin—lymphatic system cancer	0.000647	0.00296	CcSEcCtD
Desipramine—Vision blurred—Carmustine—lymphatic system cancer	0.000646	0.00296	CcSEcCtD
Desipramine—Tremor—Carmustine—lymphatic system cancer	0.000643	0.00294	CcSEcCtD
Desipramine—Oedema—Bleomycin—lymphatic system cancer	0.000641	0.00294	CcSEcCtD
Desipramine—Vomiting—Teniposide—lymphatic system cancer	0.000633	0.0029	CcSEcCtD
Desipramine—Agitation—Carmustine—lymphatic system cancer	0.00063	0.00289	CcSEcCtD
Desipramine—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.000628	0.00287	CcSEcCtD
Desipramine—Asthenia—Fludarabine—lymphatic system cancer	0.000627	0.00287	CcSEcCtD
Desipramine—Rash—Teniposide—lymphatic system cancer	0.000627	0.00287	CcSEcCtD
Desipramine—Dermatitis—Teniposide—lymphatic system cancer	0.000627	0.00287	CcSEcCtD
Desipramine—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.000624	0.00286	CcSEcCtD
Desipramine—Headache—Teniposide—lymphatic system cancer	0.000623	0.00285	CcSEcCtD
Desipramine—Pruritus—Fludarabine—lymphatic system cancer	0.000619	0.00283	CcSEcCtD
Desipramine—Anorexia—Bleomycin—lymphatic system cancer	0.000611	0.0028	CcSEcCtD
Desipramine—Agitation—Vincristine—lymphatic system cancer	0.000602	0.00275	CcSEcCtD
Desipramine—Vision blurred—Mitoxantrone—lymphatic system cancer	0.000601	0.00275	CcSEcCtD
Desipramine—Hypotension—Bleomycin—lymphatic system cancer	0.000599	0.00274	CcSEcCtD
Desipramine—Diarrhoea—Fludarabine—lymphatic system cancer	0.000598	0.00274	CcSEcCtD
Desipramine—Convulsion—Carmustine—lymphatic system cancer	0.000594	0.00272	CcSEcCtD
Desipramine—Hypertension—Carmustine—lymphatic system cancer	0.000592	0.00271	CcSEcCtD
Desipramine—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.000592	0.00271	CcSEcCtD
Desipramine—Nausea—Teniposide—lymphatic system cancer	0.000591	0.00271	CcSEcCtD
Desipramine—Anxiety—Carmustine—lymphatic system cancer	0.000582	0.00266	CcSEcCtD
Desipramine—Paraesthesia—Bleomycin—lymphatic system cancer	0.000576	0.00264	CcSEcCtD
Desipramine—Malaise—Mitoxantrone—lymphatic system cancer	0.000575	0.00263	CcSEcCtD
Desipramine—Convulsion—Vincristine—lymphatic system cancer	0.000567	0.0026	CcSEcCtD
Desipramine—Hypertension—Vincristine—lymphatic system cancer	0.000565	0.00259	CcSEcCtD
Desipramine—Confusional state—Carmustine—lymphatic system cancer	0.000564	0.00258	CcSEcCtD
Desipramine—Oedema—Carmustine—lymphatic system cancer	0.00056	0.00256	CcSEcCtD
Desipramine—Decreased appetite—Bleomycin—lymphatic system cancer	0.000557	0.00255	CcSEcCtD
Desipramine—Vomiting—Fludarabine—lymphatic system cancer	0.000556	0.00255	CcSEcCtD
Desipramine—Convulsion—Mitoxantrone—lymphatic system cancer	0.000552	0.00253	CcSEcCtD
Desipramine—Rash—Fludarabine—lymphatic system cancer	0.000551	0.00252	CcSEcCtD
Desipramine—Dermatitis—Fludarabine—lymphatic system cancer	0.000551	0.00252	CcSEcCtD
Desipramine—Hypertension—Mitoxantrone—lymphatic system cancer	0.00055	0.00252	CcSEcCtD
Desipramine—Thrombocytopenia—Carmustine—lymphatic system cancer	0.000548	0.00251	CcSEcCtD
Desipramine—Headache—Fludarabine—lymphatic system cancer	0.000548	0.00251	CcSEcCtD
Desipramine—Tachycardia—Carmustine—lymphatic system cancer	0.000546	0.0025	CcSEcCtD
Desipramine—Anxiety—Mitoxantrone—lymphatic system cancer	0.000541	0.00248	CcSEcCtD
Desipramine—Cerebrovascular accident—Methotrexate—lymphatic system cancer	0.000538	0.00246	CcSEcCtD
Desipramine—Discomfort—Mitoxantrone—lymphatic system cancer	0.000536	0.00246	CcSEcCtD
Desipramine—Oedema—Vincristine—lymphatic system cancer	0.000534	0.00245	CcSEcCtD
Desipramine—Anorexia—Carmustine—lymphatic system cancer	0.000534	0.00244	CcSEcCtD
Desipramine—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000528	0.00242	CcSEcCtD
Desipramine—Confusional state—Mitoxantrone—lymphatic system cancer	0.000525	0.0024	CcSEcCtD
Desipramine—Thrombocytopenia—Vincristine—lymphatic system cancer	0.000523	0.00239	CcSEcCtD
Desipramine—Hypotension—Carmustine—lymphatic system cancer	0.000523	0.00239	CcSEcCtD
Desipramine—Oedema—Mitoxantrone—lymphatic system cancer	0.00052	0.00238	CcSEcCtD
Desipramine—Nausea—Fludarabine—lymphatic system cancer	0.000519	0.00238	CcSEcCtD
Desipramine—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.000509	0.00233	CcSEcCtD
Desipramine—Urticaria—Bleomycin—lymphatic system cancer	0.000509	0.00233	CcSEcCtD
Desipramine—Anorexia—Vincristine—lymphatic system cancer	0.000509	0.00233	CcSEcCtD
Desipramine—Tachycardia—Mitoxantrone—lymphatic system cancer	0.000508	0.00232	CcSEcCtD
Desipramine—Body temperature increased—Bleomycin—lymphatic system cancer	0.000507	0.00232	CcSEcCtD
Desipramine—Insomnia—Carmustine—lymphatic system cancer	0.000506	0.00232	CcSEcCtD
Desipramine—Paraesthesia—Carmustine—lymphatic system cancer	0.000503	0.0023	CcSEcCtD
Desipramine—Hypotension—Vincristine—lymphatic system cancer	0.000499	0.00229	CcSEcCtD
Desipramine—Somnolence—Carmustine—lymphatic system cancer	0.000498	0.00228	CcSEcCtD
Desipramine—Anorexia—Mitoxantrone—lymphatic system cancer	0.000496	0.00227	CcSEcCtD
Desipramine—Ataxia—Methotrexate—lymphatic system cancer	0.000496	0.00227	CcSEcCtD
Desipramine—Liver function test abnormal—Methotrexate—lymphatic system cancer	0.000487	0.00223	CcSEcCtD
Desipramine—Decreased appetite—Carmustine—lymphatic system cancer	0.000487	0.00223	CcSEcCtD
Desipramine—Hypotension—Mitoxantrone—lymphatic system cancer	0.000486	0.00223	CcSEcCtD
Desipramine—Insomnia—Vincristine—lymphatic system cancer	0.000483	0.00221	CcSEcCtD
Desipramine—Paraesthesia—Vincristine—lymphatic system cancer	0.00048	0.0022	CcSEcCtD
Desipramine—Constipation—Carmustine—lymphatic system cancer	0.000479	0.00219	CcSEcCtD
Desipramine—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.000467	0.00214	CcSEcCtD
Desipramine—Decreased appetite—Vincristine—lymphatic system cancer	0.000464	0.00213	CcSEcCtD
Desipramine—Somnolence—Mitoxantrone—lymphatic system cancer	0.000463	0.00212	CcSEcCtD
Desipramine—Feeling abnormal—Carmustine—lymphatic system cancer	0.000461	0.00211	CcSEcCtD
Desipramine—Fatigue—Vincristine—lymphatic system cancer	0.000461	0.00211	CcSEcCtD
Desipramine—Asthenia—Bleomycin—lymphatic system cancer	0.00046	0.00211	CcSEcCtD
Desipramine—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.000458	0.0021	CcSEcCtD
Desipramine—Constipation—Vincristine—lymphatic system cancer	0.000457	0.00209	CcSEcCtD
Desipramine—Pruritus—Bleomycin—lymphatic system cancer	0.000454	0.00208	CcSEcCtD
Desipramine—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000452	0.00207	CcSEcCtD
Desipramine—Eosinophilia—Methotrexate—lymphatic system cancer	0.000451	0.00207	CcSEcCtD
Desipramine—Fatigue—Mitoxantrone—lymphatic system cancer	0.000449	0.00205	CcSEcCtD
Desipramine—Constipation—Mitoxantrone—lymphatic system cancer	0.000445	0.00204	CcSEcCtD
Desipramine—Abdominal pain—Carmustine—lymphatic system cancer	0.000442	0.00203	CcSEcCtD
Desipramine—Body temperature increased—Carmustine—lymphatic system cancer	0.000442	0.00203	CcSEcCtD
Desipramine—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000429	0.00196	CcSEcCtD
Desipramine—Abdominal pain—Vincristine—lymphatic system cancer	0.000422	0.00193	CcSEcCtD
Desipramine—Body temperature increased—Vincristine—lymphatic system cancer	0.000422	0.00193	CcSEcCtD
Desipramine—Erectile dysfunction—Methotrexate—lymphatic system cancer	0.00042	0.00192	CcSEcCtD
Desipramine—Urticaria—Mitoxantrone—lymphatic system cancer	0.000413	0.00189	CcSEcCtD
Desipramine—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000411	0.00188	CcSEcCtD
Desipramine—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000411	0.00188	CcSEcCtD
Desipramine—Vomiting—Bleomycin—lymphatic system cancer	0.000408	0.00187	CcSEcCtD
Desipramine—Drowsiness—Methotrexate—lymphatic system cancer	0.000407	0.00186	CcSEcCtD
Desipramine—Depression—Methotrexate—lymphatic system cancer	0.000405	0.00186	CcSEcCtD
Desipramine—Rash—Bleomycin—lymphatic system cancer	0.000404	0.00185	CcSEcCtD
Desipramine—Dermatitis—Bleomycin—lymphatic system cancer	0.000404	0.00185	CcSEcCtD
Desipramine—Asthenia—Carmustine—lymphatic system cancer	0.000402	0.00184	CcSEcCtD
Desipramine—Stomatitis—Methotrexate—lymphatic system cancer	0.000396	0.00181	CcSEcCtD
Desipramine—Asthenia—Vincristine—lymphatic system cancer	0.000383	0.00176	CcSEcCtD
Desipramine—Diarrhoea—Carmustine—lymphatic system cancer	0.000383	0.00175	CcSEcCtD
Desipramine—Nausea—Bleomycin—lymphatic system cancer	0.000381	0.00174	CcSEcCtD
Desipramine—Agranulocytosis—Methotrexate—lymphatic system cancer	0.000379	0.00174	CcSEcCtD
Desipramine—Asthenia—Mitoxantrone—lymphatic system cancer	0.000373	0.00171	CcSEcCtD
Desipramine—Dizziness—Carmustine—lymphatic system cancer	0.00037	0.00169	CcSEcCtD
Desipramine—Diarrhoea—Vincristine—lymphatic system cancer	0.000366	0.00167	CcSEcCtD
Desipramine—Hepatitis—Methotrexate—lymphatic system cancer	0.000365	0.00167	CcSEcCtD
Desipramine—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000356	0.00163	CcSEcCtD
Desipramine—Vomiting—Carmustine—lymphatic system cancer	0.000356	0.00163	CcSEcCtD
Desipramine—Dizziness—Vincristine—lymphatic system cancer	0.000353	0.00162	CcSEcCtD
Desipramine—Rash—Carmustine—lymphatic system cancer	0.000353	0.00162	CcSEcCtD
Desipramine—Dermatitis—Carmustine—lymphatic system cancer	0.000353	0.00161	CcSEcCtD
Desipramine—Headache—Carmustine—lymphatic system cancer	0.000351	0.00161	CcSEcCtD
Desipramine—Tinnitus—Methotrexate—lymphatic system cancer	0.00034	0.00156	CcSEcCtD
Desipramine—Vomiting—Vincristine—lymphatic system cancer	0.00034	0.00156	CcSEcCtD
Desipramine—Rash—Vincristine—lymphatic system cancer	0.000337	0.00154	CcSEcCtD
Desipramine—Dermatitis—Vincristine—lymphatic system cancer	0.000337	0.00154	CcSEcCtD
Desipramine—Headache—Vincristine—lymphatic system cancer	0.000335	0.00153	CcSEcCtD
Desipramine—Nausea—Carmustine—lymphatic system cancer	0.000332	0.00152	CcSEcCtD
Desipramine—Vomiting—Mitoxantrone—lymphatic system cancer	0.000331	0.00151	CcSEcCtD
Desipramine—Rash—Mitoxantrone—lymphatic system cancer	0.000328	0.0015	CcSEcCtD
Desipramine—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000328	0.0015	CcSEcCtD
Desipramine—Headache—Mitoxantrone—lymphatic system cancer	0.000326	0.00149	CcSEcCtD
Desipramine—Alopecia—Methotrexate—lymphatic system cancer	0.000322	0.00148	CcSEcCtD
Desipramine—Nausea—Vincristine—lymphatic system cancer	0.000317	0.00145	CcSEcCtD
Desipramine—Dysgeusia—Methotrexate—lymphatic system cancer	0.000311	0.00142	CcSEcCtD
Desipramine—Nausea—Mitoxantrone—lymphatic system cancer	0.000309	0.00141	CcSEcCtD
Desipramine—Vision blurred—Methotrexate—lymphatic system cancer	0.000299	0.00137	CcSEcCtD
Desipramine—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000295	0.00135	CcSEcCtD
Desipramine—Malaise—Methotrexate—lymphatic system cancer	0.000286	0.00131	CcSEcCtD
Desipramine—Convulsion—Methotrexate—lymphatic system cancer	0.000275	0.00126	CcSEcCtD
Desipramine—Discomfort—Methotrexate—lymphatic system cancer	0.000267	0.00122	CcSEcCtD
Desipramine—Confusional state—Methotrexate—lymphatic system cancer	0.000261	0.0012	CcSEcCtD
Desipramine—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000254	0.00116	CcSEcCtD
Desipramine—Anorexia—Methotrexate—lymphatic system cancer	0.000247	0.00113	CcSEcCtD
Desipramine—Hypotension—Methotrexate—lymphatic system cancer	0.000242	0.00111	CcSEcCtD
Desipramine—Insomnia—Methotrexate—lymphatic system cancer	0.000234	0.00107	CcSEcCtD
Desipramine—Paraesthesia—Methotrexate—lymphatic system cancer	0.000233	0.00107	CcSEcCtD
Desipramine—Somnolence—Methotrexate—lymphatic system cancer	0.00023	0.00106	CcSEcCtD
Desipramine—Dyspepsia—Methotrexate—lymphatic system cancer	0.000228	0.00104	CcSEcCtD
Desipramine—Decreased appetite—Methotrexate—lymphatic system cancer	0.000225	0.00103	CcSEcCtD
Desipramine—Fatigue—Methotrexate—lymphatic system cancer	0.000224	0.00102	CcSEcCtD
Desipramine—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000214	0.000978	CcSEcCtD
Desipramine—Urticaria—Methotrexate—lymphatic system cancer	0.000206	0.000943	CcSEcCtD
Desipramine—Abdominal pain—Methotrexate—lymphatic system cancer	0.000205	0.000938	CcSEcCtD
Desipramine—Body temperature increased—Methotrexate—lymphatic system cancer	0.000205	0.000938	CcSEcCtD
Desipramine—Asthenia—Methotrexate—lymphatic system cancer	0.000186	0.000852	CcSEcCtD
Desipramine—Pruritus—Methotrexate—lymphatic system cancer	0.000183	0.00084	CcSEcCtD
Desipramine—Diarrhoea—Methotrexate—lymphatic system cancer	0.000177	0.000812	CcSEcCtD
Desipramine—Dizziness—Methotrexate—lymphatic system cancer	0.000171	0.000785	CcSEcCtD
Desipramine—Vomiting—Methotrexate—lymphatic system cancer	0.000165	0.000755	CcSEcCtD
Desipramine—Rash—Methotrexate—lymphatic system cancer	0.000163	0.000748	CcSEcCtD
Desipramine—Dermatitis—Methotrexate—lymphatic system cancer	0.000163	0.000748	CcSEcCtD
Desipramine—Headache—Methotrexate—lymphatic system cancer	0.000162	0.000744	CcSEcCtD
Desipramine—Nausea—Methotrexate—lymphatic system cancer	0.000154	0.000705	CcSEcCtD
